300 related articles for article (PubMed ID: 18836588)
1. Therapy directed against thymic stromal lymphopoietin.
Edwards MJ
Drug News Perspect; 2008; 21(6):312-6. PubMed ID: 18836588
[TBL] [Abstract][Full Text] [Related]
2. Early production of thymic stromal lymphopoietin precedes infiltration of dendritic cells expressing its receptor in allergen-induced late phase cutaneous responses in atopic subjects.
Corrigan CJ; Jayaratnam A; Wang Y; Liu Y; de Waal Malefyt R; Meng Q; Kay AB; Phipps S; Lee TH; Ying S
Allergy; 2009 Jul; 64(7):1014-22. PubMed ID: 19187393
[TBL] [Abstract][Full Text] [Related]
3. Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma.
Cheng DT; Ma C; Niewoehner J; Dahl M; Tsai A; Zhang J; Gonsiorek W; Apparsundaram S; Pashine A; Ravindran P; Jung J; Hang J; Allard J; Bitter H; Tribouley C; Narula S; Wilson S; Fuentes ME
J Allergy Clin Immunol; 2013 Aug; 132(2):455-62. PubMed ID: 23810153
[TBL] [Abstract][Full Text] [Related]
4. Expression and Regulation of Thymic Stromal Lymphopoietin and Thymic Stromal Lymphopoietin Receptor Heterocomplex in the Innate-Adaptive Immunity of Pediatric Asthma.
Lin SC; Cheng FY; Liu JJ; Ye YL
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670037
[TBL] [Abstract][Full Text] [Related]
5. Thymic stromal lymphopoietin, OX40-ligand, and interleukin-25 in allergic responses.
Wang YH; Liu YJ
Clin Exp Allergy; 2009 Jun; 39(6):798-806. PubMed ID: 19400908
[TBL] [Abstract][Full Text] [Related]
6. T cell-mediated induction of thymic stromal lymphopoietin in differentiated human primary bronchial epithelial cells.
Hui CC; Murphy DM; Neighbour H; Al-Sayegh M; O'Byrne S; Thong B; Denburg JA; Larché M
Clin Exp Allergy; 2014 Jul; 44(7):953-64. PubMed ID: 24773145
[TBL] [Abstract][Full Text] [Related]
7. Thymic stromal lymphopoietin: a promising therapeutic target for allergic diseases.
Wang WL; Li HY; Zhang MS; Gao PS; He SH; Zheng T; Zhu Z; Zhou LF
Int Arch Allergy Immunol; 2013; 160(1):18-26. PubMed ID: 22948028
[TBL] [Abstract][Full Text] [Related]
8. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP.
Soumelis V; Reche PA; Kanzler H; Yuan W; Edward G; Homey B; Gilliet M; Ho S; Antonenko S; Lauerma A; Smith K; Gorman D; Zurawski S; Abrams J; Menon S; McClanahan T; de Waal-Malefyt Rd R; Bazan F; Kastelein RA; Liu YJ
Nat Immunol; 2002 Jul; 3(7):673-80. PubMed ID: 12055625
[TBL] [Abstract][Full Text] [Related]
9. Myeloid dendritic cells are primed in allergic asthma for thymic stromal lymphopoietin-mediated induction of Th2 and Th9 responses.
Froidure A; Shen C; Gras D; Van Snick J; Chanez P; Pilette C
Allergy; 2014 Aug; 69(8):1068-76. PubMed ID: 24888572
[TBL] [Abstract][Full Text] [Related]
10. Human thymic stromal lymphopoietin: a novel epithelial cell-derived cytokine and a potential key player in the induction of allergic inflammation.
Soumelis V; Liu YJ
Springer Semin Immunopathol; 2004 Feb; 25(3-4):325-33. PubMed ID: 14999427
[TBL] [Abstract][Full Text] [Related]
11. Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFkappaB.
Lee HC; Ziegler SF
Proc Natl Acad Sci U S A; 2007 Jan; 104(3):914-9. PubMed ID: 17213320
[TBL] [Abstract][Full Text] [Related]
12. Cellular and molecular mechanisms of TSLP function in human allergic disorders--TSLP programs the "Th2 code" in dendritic cells.
Ito T; Liu YJ; Arima K
Allergol Int; 2012 Mar; 61(1):35-43. PubMed ID: 22189594
[TBL] [Abstract][Full Text] [Related]
13. Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation.
Liu YJ
J Allergy Clin Immunol; 2007 Aug; 120(2):238-44; quiz 245-6. PubMed ID: 17666213
[TBL] [Abstract][Full Text] [Related]
14. Human TSLP and TLR3 ligands promote differentiation of Th17 cells with a central memory phenotype under Th2-polarizing conditions.
Tanaka J; Watanabe N; Kido M; Saga K; Akamatsu T; Nishio A; Chiba T
Clin Exp Allergy; 2009 Jan; 39(1):89-100. PubMed ID: 19055649
[TBL] [Abstract][Full Text] [Related]
15. Thymic stromal lymphopoietin-induced interleukin-17A is involved in the development of IgE-mediated atopic dermatitis-like skin lesions in mice.
Mizutani N; Sae-Wong C; Kangsanant S; Nabe T; Yoshino S
Immunology; 2015 Dec; 146(4):568-81. PubMed ID: 26310839
[TBL] [Abstract][Full Text] [Related]
16. [Search for Compounds Regulating TSLP Production].
Segawa R
Yakugaku Zasshi; 2021; 141(10):1129-1135. PubMed ID: 34602509
[TBL] [Abstract][Full Text] [Related]
17. Exosomes from Thymic Stromal Lymphopoietin-Activated Dendritic Cells Promote Th2 Differentiation through the OX40 Ligand.
Huang L; Zhang X; Wang M; Chen Z; Yan Y; Gu W; Tan J; Jiang W; Ji W
Pathobiology; 2019; 86(2-3):111-117. PubMed ID: 30408778
[TBL] [Abstract][Full Text] [Related]
18. Thymic stromal lymphopoietin promotes lung inflammation through activation of dendritic cells.
Li YL; Li HJ; Ji F; Zhang X; Wang R; Hao JQ; Bi WX; Dong L
J Asthma; 2010 Mar; 47(2):117-23. PubMed ID: 20170316
[TBL] [Abstract][Full Text] [Related]
19. Thymic stromal lymphopoietin:a potential therapeutic target for allergy and asthma.
Huston DP; Liu YJ
Curr Allergy Asthma Rep; 2006 Sep; 6(5):372-6. PubMed ID: 16899198
[TBL] [Abstract][Full Text] [Related]
20. IL-33 promotes the induction and maintenance of Th2 immune responses by enhancing the function of OX40 ligand.
Murakami-Satsutani N; Ito T; Nakanishi T; Inagaki N; Tanaka A; Vien PT; Kibata K; Inaba M; Nomura S
Allergol Int; 2014 Sep; 63(3):443-55. PubMed ID: 24851948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
